Type II nitric oxide synthase activity is cardio-protective in experimental sepsis

Author： Price S. Mitchell J.A. Anning P.B. Evans T.W.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.472, Iss.1, 2003-07, pp. : 111-118

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Methods to Evaluate the Activity of Nitric Oxide Synthase

Current Pharmaceutical Analysis, Vol. 13, Iss. 5, 2017-08 ,pp. : 411-416

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of water deprivation and angiotensin II intracerebroventricular administration on brain nitric oxide synthase activity

By Calapai G. Marciano M.C. Costantino G. Russo A. Corica F. Sautebin L. Di Rosa M. Caputi A.P.

European Journal of Pharmacology, Vol. 360, Iss. 2, 1998-11 ,pp. : 147-154

Elsevier

Access to resources Recommend Favorite

Nitric oxide synthase inhibitors for the treatment of chronic tension-type headache

By Ashina Messoud

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 4, 2002-04 ,pp. : 395-399

Informa Healthcare

Access to resources Recommend Favorite

Nitric oxide synthase inhibitors

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 7, 2000-07 ,pp. : 1143-1146

Informa Healthcare

Access to resources Recommend Favorite

Nitric oxide synthase inhibitors

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. : 1207-1210

Informa Healthcare

Access to resources Recommend Favorite